title: Clobazam, ezogabine, and tafluprost.
authors: Philadelphia College of Pharmacy, University of Sciences in Philadelphia, PA, USA.
authors: Daniel A
authors: DA
authors: Hussar
authors: Sarah E
authors: SE
authors: Hallinan
mesh_terms: D000927:Anticonvulsants / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use*; D002219:Carbamates / Q000627:therapeutic use*; D000078306:Clobazam; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy*; D065768:Lennox Gastaut Syndrome; D010655:Phenylenediamines / Q000627:therapeutic use*; D011460:Prostaglandins F / Q000627:therapeutic use*; D012640:Seizures / Q000188:drug therapy*; D013036:Spasms, Infantile / Q000188:drug therapy*
chemical_list: D000927:Anticonvulsants; D002219:Carbamates; D010655:Phenylenediamines; D011460:Prostaglandins F; D001569:Benzodiazepines; C101866:ezogabine; C485333:tafluprost; D000078306:Clobazam